Myelofibrosis

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instanceOf gptkb:disease
Myeloproliferative neoplasm
gptkbp:abbreviation MF
gptkbp:affectsOrgan gptkb:Bone_marrow
gptkbp:cause Leukemia
Portal hypertension
Extramedullary hematopoiesis
gptkbp:causedBy gptkb:JAK2_mutation
CALR mutation
MPL mutation
gptkbp:characterizedBy Fibrosis of bone marrow
gptkbp:complication Infections
Bleeding
Thrombosis
gptkbp:diagnosedBy Blood test
Bone marrow biopsy
gptkbp:firstDescribed 1879
gptkbp:hasEpidemiology Affects 1-2 per 100,000 per year
gptkbp:hasMedianAgeOfOnset 60 years
gptkbp:hasOrphanetID ORPHA:732
https://www.w3.org/2000/01/rdf-schema#label Myelofibrosis
gptkbp:ICD-10_code D47.4
gptkbp:inheritance Sporadic
gptkbp:MeSH_ID D009196
gptkbp:mortalityRate High in advanced stages
gptkbp:OMIM 254450
gptkbp:pathology Leukoerythroblastosis
Megakaryocyte proliferation
Reticulin fibrosis
gptkbp:prevalence Rare
gptkbp:prognosis Variable
gptkbp:riskFactor Male sex
Older age
Exposure to toxins
gptkbp:subclassOf Chronic myeloproliferative disorder
gptkbp:symptom gptkb:anemia
Weight loss
Fatigue
Splenomegaly
Night sweats
Bone pain
gptkbp:synonym Agnogenic myeloid metaplasia
Chronic idiopathic myelofibrosis
Primary myelofibrosis
gptkbp:treatment gptkb:Hydroxyurea
Ruxolitinib
Allogeneic stem cell transplantation
Fedratinib
gptkbp:bfsParent gptkb:Elliptocytes
gptkbp:bfsLayer 8